UNS
Click for more information
0.00% 0.5¢ unilife corporation

forbes article

  1. TheBryMan
    22 Posts.
    clock Created with Sketch.
    04/09/13
    22:07
    Post #: 12288635
    http://www.forbes.com/sites/abrambrown/2013/09/04/how-is-a-329m-syringe-company-still-unprofitable-after-11-years/?partner=yahoomag
    UNS Price at posting: 73.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.